Shares of Lululemon Athletica Inc. (NASDAQ:LULU – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the twenty-nine ratings firms that are presently covering the stock, Marketbeat reports. Two analysts have rated the stock with a sell recommendation, five have given a hold recommendation and twenty-two have given a buy recommendation […]
AZEK (NYSE:AZEK – Get Free Report) had its price target raised by analysts at Robert W. Baird from $52.00 to $60.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Robert W. Baird’s price objective points to a potential upside of 19.45% from the company’s […]
Robinhood Markets (NASDAQ:HOOD – Get Free Report) had its price target upped by research analysts at Barclays from $11.00 to $16.00 in a research report issued on Monday, Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price objective indicates a potential downside of 13.79% from the company’s current price. Other […]
Rumble Inc. (NASDAQ:RUM – Get Free Report) Director Robert Arsov sold 35,000 shares of the firm’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $6.72, for a total transaction of $235,200.00. Following the completion of the sale, the director now owns 15,348,914 shares of the company’s […]
Truist Financial reissued their buy rating on shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. Truist Financial currently has a $1,135.00 price target on the biopharmaceutical company’s stock. REGN has been the subject of a number of other reports. Cantor Fitzgerald raised their price […]